News for CareDx, Inc (CDNA)

Company positions for long-term growth in medical device markets Salt Lake City, UT, April 03, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ( SINT), an

U.S. stock futures were lower this morning, with the Dow futures falling more than 250 points on Monday.

PHILADELPHIA, March 19, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against CareDx, Inc. ( CDNA)

Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox, Repare Therapeutics, and CareDx.

CareDx continues its growth trajectory with solid margins and EBITDA. Find out why CDNA stock offers a promising outlook after legal resolutions.

CareDx, Inc. (Nasdaq: CDNA) ”“ The Transplant Companyâ„¢ ”“ a leading precision medicine company focused on the discovery, development, and commercialization

Small Cap Opportunity Fund A Shares (without sales charge*) posted a return of -1.72% in fourth quarter 2024. Read more here.

CareDx Inc (CDNA), a company specializing in medical services and tests for transplant recipients, is currently under scrutiny as Kahn Swick & Foti, LLC (KSF) c

Strengths: Innovative product portfolio and strong market presence in transplantation diagnostics.Weaknesses: History of losses and reliance on Medicare reimbu

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Release Date: February 26, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points CareDx Inc (

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NCDNA.OQ - CareDx IncQ4 2024 CareDx Inc Earnings CallFeb 26, 2025 / 09:30PM GMT ===============

The following slide deck was published by CareDx, Inc in conjunction with their 2024 Q4 earnings call.

CareDx, Inc (NASDAQ:CDNA) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ETCompany ParticipantsCaroline Corner - Investor RelationsJohn Hanna -...

Although the revenue and EPS for CareDx (CDNA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Quarterly Revenue: $86.6 million, surpassing the estimated $84.12 million, marking a 32% increase year-over-year.Quarterly EPS: Reported at $1.51, significantl

CareDx Inc (CDNA) announced its financial results for the fourth quarter and full year ending December 31, 2024, showcasing a robust performance with a 32% year

CareDx, Inc. (Nasdaq: CDNA) today reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter Financial Highlight

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Wednesday. Shares of Flywire Corporation FLYW fell sharply in to...